Search form
Search
contact us
Navigation
home
boards
Jobs
job ratings
cp wire
medtech news
pharmagather
catering
advertise
whistleblower info
pharmaceutical fraud
medical device | DME fraud
clinical lab fraud
False Claims Act
Legal Help
login/register
You are here
Home
» Celgene bags a build-to-buy biotech in $485M cancer deal
Celgene bags a build-to-buy biotech in $485M cancer deal
Celgene bags a build-to-buy biotech in $485M cancer deal
Submitted by
admin
on April 27, 2015 - 9:49am
Source:
Fierce Biotech
News Tags:
Celgene
M&A
Quanticel Pharmaceuticals
cancer
R&D
Headline:
Celgene bags a build-to-buy biotech in $485M cancer deal
Do Not Allow Advertisers to Use My Personal information
